Clinical Trials
79 trials177Lu-LNC1011 in Patients with Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital
Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer
Sinotau Pharmaceutical Group
LUCIDA
FutureChem
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
Eutilex
Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological Tumors
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Enzalutamide and Indomethacin in Treating Patients With Recurrent or Metastatic Hormone-Resistant Prostate Cancer
University of California, Davis
First in Man Clinical Study to Evaluate Safety and Tolerability of an Oncolytic Adenovirus in Prostate Cancer Patients.
Orca Therapeutics B.V.
Phase 1/2 Clinical Study of HRS-4357 in Patients With Advanced Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.
A Clinical Trial of KVA12123 Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
Kineta Inc.
ICEMELT
Western Sydney Local Health District
Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell Carcinoma
Tabriz University of Medical Sciences
A Study of ICP-192 in Patients With Advanced Solid Tumors
Beijing InnoCare Pharma Tech Co., Ltd.
REGOMUNE
Institut Bergonié
Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine
LintonPharm Co.,Ltd.
68Ga-P15-041 and 68Ga-PSMA-11 PET/CT Imaging in the Same Group of Prostate Bone Metastasis
Peking Union Medical College Hospital
Vaccine Therapy in Curative Resected Prostate Cancer Patients
Oslo University Hospital
CAPER
The Christie NHS Foundation Trust
DETECT
Radboud University Medical Center
64Cu-SAR-bisPSMA Positron Emission Tomography of Patients With Known or Suspected Prostate Cancer
GU Research Network, LLC
CROP
Sunnybrook Health Sciences Centre
ANTICIPATE
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Treatment of Metastatic Tumors of the Urogenital Area With Cytokine-induced Killer Cells
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
South East Technological University
A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547
Abbisko Therapeutics Co, Ltd
TACBIN-01
RenJi Hospital
CoA-CRPC
Jiangnan University
SOROCOV
Butantan Institute
pHART8
Sunnybrook Health Sciences Centre
SATURN
Sunnybrook Health Sciences Centre
2STAR
Sunnybrook Health Sciences Centre
A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer
Hamlet Pharma AB
mCRPC
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
PSMA-specific CAR-T Cell Therapy
Shenzhen Geno-Immune Medical Institute
A Safety and Efficacy Study of SHR3680 in Metastatic Castration-Resistant Prostate Cancer Patients
Jiangsu HengRui Medicine Co., Ltd.
A Study of RC48-ADC(Antibody Drug Conjugate) and JS001 to Evaluate the Safety and Pharmacokinetics of Subjects With Locally Advanced or Metastatic Urothelial Cancer
Peking University Cancer Hospital & Institute
Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies
Shenzhen BinDeBio Ltd.
A Trial of Paclitaxel (Albumin-binding) for Castration-resistant Prostate Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Intervention of CAR-T Against Cervical Cancer
Shenzhen Geno-Immune Medical Institute
Antigen-specific T Cells Against Lung Cancer
Shenzhen Geno-Immune Medical Institute
A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer
Guangzhou University of Traditional Chinese Medicine
A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Locally Advanced and Metastatic Urothelial Carcinoma
Lee's Pharmaceutical Limited
Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)
King Faisal Specialist Hospital & Research Center
A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer
Xiangya Hospital of Central South University
Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment
The First Affiliated Hospital of Guangdong Pharmaceutical University
A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer
Panacela Labs LLC
UroRCC
University Hospital Tuebingen
Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy
University Hospital Tuebingen
Bortezomib and Bevacizumab ("BB-mib-mab") in Patients With Advanced or Recurrent Renal Cell Cancer (RCC)
University of Southern California
Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC
Shanghai AbelZeta Ltd.